Live from the NIH registry
Studies recruiting near Pomona right now
Top 25 of 3,184 recruiting studies, sorted by proximity — each links to its official registry page
One-Time DNA Study for Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Giant Cell Arteritis
N/A
Observational 1,000 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (27.5 mi)
· Sponsor: University of Pennsylvania
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
City of Hope (Adults and Pediatrics) — Duarte, California (13.5 mi)
· Sponsor: Pierre Fabre Medicament
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
City of Hope — Duarte, California (13.5 mi)
· Sponsor: Syndax Pharmaceuticals
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (19.4 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
Prostate Carcinoma
N/A
Observational 300 participants sought
Los Angeles General Medical Center — Los Angeles, California (27.5 mi)
· Sponsor: University of Southern California
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Urology Group of Southern California — Los Angeles, California (27.5 mi)
· Sponsor: Pacific Edge Limited
Access to Genetic Testing in Underserved Patients With Cancer
Breast Carcinoma, Male Breast Carcinoma
N/A
Interventional 800 participants sought
USC / Norris Comprehensive Cancer Center — Los Angeles, California (27.5 mi)
· Sponsor: University of Southern California
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (27.5 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (27.5 mi)
· Sponsor: Westat
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (13.5 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Artemis Institute for Clinical Research — Riverside, California (22.2 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (28.7 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Ovarian Cancer
Phase 1
Interventional 285 participants sought
City of Hope National Medical Center /ID# 281381 — Duarte, California (13.5 mi)
· Sponsor: AbbVie
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
Phase 1
Interventional 127 participants sought
City of Hope National Medical Center /ID# 280273 — Duarte, California (13.5 mi)
· Sponsor: AbbVie
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Win Retina — Arcadia, California (16.6 mi)
· Sponsor: Boehringer Ingelheim
Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Low-Risk, Early Stage Breast Cancer
N/A
Interventional 400 participants sought
Glendale Adventist Medical Center d/b/a Adventist Health Glendale — Glendale, California (28.8 mi)
· Sponsor: IceCure Medical Ltd.
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University of Southern California-Children's Hospital — Los Angeles, California (27.5 mi)
· Sponsor: University of Michigan
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma
Phase 1, Phase 2
Interventional 78 participants sought
City of Hope Medical Center — Duarte, California (13.5 mi)
· Sponsor: City of Hope Medical Center
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
NK-Cell Lymphoma, NK-Cell Leukemia
EARLY/Phase 1
Interventional 40 participants sought
Children's Hospital Orange County — Orange, California (19.4 mi)
· Sponsor: New York Medical College
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Cedars-Sinai Medical Center — Los Angeles, California (27.5 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (19.4 mi)
· Sponsor: University of California, Irvine
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
California Research Institute — Los Angeles, California (27.5 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (19.4 mi)
· Sponsor: National Cancer Institute (NCI)
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease
Phase 1, Phase 2
Interventional 54 participants sought
UCLA TMS Clinical and Research Service — Los Angeles, California (27.5 mi)
· Sponsor: University of California, Los Angeles
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Cancer and Blood Specialty Clinic — Los Alamitos, California (25.0 mi)
· Sponsor: Hoffmann-La Roche